Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.2000 (2.56%) ($6.5000 - $7.3000) on Fri. Aug. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.1% (three month average) | RSI | 64 | Latest Price | $7.2000(2.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.1% a day on average for past five trading days. | Weekly Trend | ANPC advances 9.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(10%) LIT(8%) UUP(8%) IGOV(7%) TLT(7%) | Factors Impacting ANPC price | ANPC will decline at least -4.05% in a week (0% probabilities). SHY(-26%) IBB(-9%) XLU(-7%) XBI(-7%) VCSH(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.05% (StdDev 8.1%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $7.22(-0.28%) | 10 Day Moving Average | $6.71(7.3%) | 20 Day Moving Average | $6.25(15.2%) | To recent high | -10% | To recent low | 41.5% | Market Cap | $61m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |